Founders Capital Management Johnson & Johnson Transaction History

Founders Capital Management

$148 Million
Q1 2024

A detailed history of Founders Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Founders Capital Management holds 18,744 shares of JNJ stock, worth $2.73 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

18,744

Previous 18,745 0.01%

Holding current value

$2.73 Million

Previous $2.94 Million 0.92%

% of portfolio

2.01%

Previous 2.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$155.22 - $162.74 $155 - $162	-1 Reduced 0.01%	18,744 $2.97 Million
Q4 2023 Jan 08, 2024	SELL	$145.6 - $158.88 $51,251 - $55,925	-352 Reduced 1.84%	18,745 $2.94 Million
Q3 2023 Oct 10, 2023	BUY	$155.75 - $174.48 $130,830 - $146,563	840 Added 4.6%	19,097 $2.97 Million
Q2 2023 Jul 07, 2023	SELL	$154.35 - $166.11 $115,145 - $123,918	-746 Reduced 3.93%	18,257 $3.02 Million
Q1 2023 Apr 12, 2023	BUY	$151.05 - $180.26 $755 - $901	5 Added 0.03%	19,003 $2.95 Million

Q3 2022 Oct 06, 2022	SELL	$161.33 - $179.52 $26,942 - $29,979	-167 Reduced 0.87%	18,998 $3.1 Million
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $128,328 - $141,925	-763 Reduced 3.83%	19,165 $3.4 Million
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $1,559 - $1,730	10 Added 0.05%	19,928 $3.41 Million
Q3 2021 Oct 12, 2021	SELL	$161.5 - $179.47 $147,611 - $164,035	-914 Reduced 4.39%	19,918 $3.22 Million
Q2 2021 Jul 15, 2021	SELL	$159.48 - $171.07 $7,973 - $8,553	-50 Reduced 0.24%	20,832 $3.43 Million
Q1 2021 Jun 07, 2021	SELL	$153.07 - $170.48 $3,826 - $4,262	-25 Reduced 0.12%	20,882 $6,000
Q4 2020 Jan 12, 2021	BUY	$137.11 - $157.38 $781,252 - $896,751	5,698 Added 37.46%	20,907 $3.29 Million
Q1 2020 Apr 22, 2020	BUY	$111.14 - $153.99 $840,774 - $1.16 Million	7,565 Added 98.97%	15,209 $1.99 Million
Q4 2019 Jan 24, 2020	SELL	$127.5 - $146.44 $87,720 - $100,750	-688 Reduced 8.26%	7,644 $1.12 Million
Q4 2018 Jan 14, 2019	SELL	$122.84 - $147.84 $11,055 - $13,305	-90 Reduced 1.07%	8,332 $1.08 Million
Q3 2018 Oct 05, 2018	BUY	$121.58 - $142.88 $35,258 - $41,435	290 Added 3.57%	8,422 $1.16 Million
Q2 2018 Jul 09, 2018	SELL	$119.4 - $131.76 $6,686 - $7,378	-56 Reduced 0.68%	8,132 $987,000
Q1 2018 Apr 09, 2018	SELL	$125.1 - $148.14 $4,378 - $5,184	-35 Reduced 0.43%	8,188 $1.05 Million
Q4 2017 Jan 22, 2018	SELL	$131.22 - $143.62 $11,547 - $12,638	-88 Reduced 1.06%	8,223 $1.15 Million
Q3 2017 Oct 17, 2017	BUY	$129.47 - $135.38 $1.08 Million - $1.13 Million	8,311	8,311 $1.08 Million

Others Institutions Holding JNJ

# of Institutions

4,147

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.

Account

Founders Capital Management Johnson & Johnson Transaction History